Estrogen Therapy Linked to Higher Porphyria Cutanea Tarda Risk
Estrogen therapy has been associated with an increased risk of developing Porphyria Cutanea Tarda (PCT), a rare skin disorder. Medical studies indicate that patients undergoing estrogen treatment should be monitored for symptoms of PCT, as hormone therapy may trigger or exacerbate the condition. Awareness of this risk can aid in early diagnosis and management.
EMJ·



